Biomedical tissue: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 10: Line 10:
The collection, storage, analysis and transplantation of human tissue involves significant ethical and safety issues, and is heavily regulated. Each country sets its own framework for ensuring the safety of human tissue products.
The collection, storage, analysis and transplantation of human tissue involves significant ethical and safety issues, and is heavily regulated. Each country sets its own framework for ensuring the safety of human tissue products.


The regulation of human transplantation in the [[United Kingdom]] is set out in the [[Human Tissue Act 2004]] and managed by the [[Human Tissue Authority]].<ref name="HTA-remit">{{cite web |author=Human Tissue Authority |authorlink=Human Tissue Authority |title=Remit |url=http://www.hta.gov.uk/aboutus/remit/}}</ref>
The regulation of human transplantation in the United Kingdom is set out in the Human Tissue Act 2004 and managed by the [[Human Tissue Authority]].<ref name="HTA-remit">{{cite web |author=Human Tissue Authority |authorlink=Human Tissue Authority |title=Remit |url=http://www.hta.gov.uk/aboutus/remit/}}</ref>


Tissue banks in the [[United States|US]] are monitored by the [[Food and Drug Administration]] (FDA). The [[Code of Federal Regulations]] sets out the following topics:<ref name="CFR2003">{{cite web |author=Food and Drug Administration |authorlink=Food and Drug Administration |title=Part 1270: 'Human Tissue Intended for Transplantation' |year=2003 |work=Title 21--Food and Drugs |publisher=[[Code of Federal Regulations]] |url=http://www.access.gpo.gov/nara/cfr/waisidx_03/21cfr1270_03.html}}</ref>
Tissue banks in the [[United States|US]] are monitored by the [[Food and Drug Administration]] (FDA). The Code of Federal Regulations sets out the following topics:<ref name="CFR2003">{{cite web |author=Food and Drug Administration |authorlink=Food and Drug Administration |title=Part 1270: 'Human Tissue Intended for Transplantation' |year=2003 |work=Title 21--Food and Drugs |publisher=[[Code of Federal Regulations]] |url=http://www.access.gpo.gov/nara/cfr/waisidx_03/21cfr1270_03.html}}</ref>
* Donor Screening and Testing: the determination of donor suitability for human tissue intended for transplantation.
* Donor Screening and Testing: the determination of donor suitability for human tissue intended for transplantation.
* Procedures and Records: the written procedures and records that must be kept
* Procedures and Records: the written procedures and records that must be kept

Revision as of 17:35, 17 June 2009

WikiDoc Resources for Biomedical tissue

Articles

Most recent articles on Biomedical tissue

Most cited articles on Biomedical tissue

Review articles on Biomedical tissue

Articles on Biomedical tissue in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Biomedical tissue

Images of Biomedical tissue

Photos of Biomedical tissue

Podcasts & MP3s on Biomedical tissue

Videos on Biomedical tissue

Evidence Based Medicine

Cochrane Collaboration on Biomedical tissue

Bandolier on Biomedical tissue

TRIP on Biomedical tissue

Clinical Trials

Ongoing Trials on Biomedical tissue at Clinical Trials.gov

Trial results on Biomedical tissue

Clinical Trials on Biomedical tissue at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Biomedical tissue

NICE Guidance on Biomedical tissue

NHS PRODIGY Guidance

FDA on Biomedical tissue

CDC on Biomedical tissue

Books

Books on Biomedical tissue

News

Biomedical tissue in the news

Be alerted to news on Biomedical tissue

News trends on Biomedical tissue

Commentary

Blogs on Biomedical tissue

Definitions

Definitions of Biomedical tissue

Patient Resources / Community

Patient resources on Biomedical tissue

Discussion groups on Biomedical tissue

Patient Handouts on Biomedical tissue

Directions to Hospitals Treating Biomedical tissue

Risk calculators and risk factors for Biomedical tissue

Healthcare Provider Resources

Symptoms of Biomedical tissue

Causes & Risk Factors for Biomedical tissue

Diagnostic studies for Biomedical tissue

Treatment of Biomedical tissue

Continuing Medical Education (CME)

CME Programs on Biomedical tissue

International

Biomedical tissue en Espanol

Biomedical tissue en Francais

Business

Biomedical tissue in the Marketplace

Patents on Biomedical tissue

Experimental / Informatics

List of terms related to Biomedical tissue

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

See also: Biomedical material and Implant (medicine)

Biomedical tissue is biological tissue used for organ transplantation and medical research, particularly cancer research.

Such tissues and organs may be referred to as: implant tissue, allograft, xenograft, skin graft tissue, human transplant tissue, implant bone. Tissue is stored in tissue establishments or tissue banks under cryogenic conditions. Fluids such as blood, blood products and urine are stored in fluid banks under similar conditions.

Regulation

The collection, storage, analysis and transplantation of human tissue involves significant ethical and safety issues, and is heavily regulated. Each country sets its own framework for ensuring the safety of human tissue products.

The regulation of human transplantation in the United Kingdom is set out in the Human Tissue Act 2004 and managed by the Human Tissue Authority.[1]

Tissue banks in the US are monitored by the Food and Drug Administration (FDA). The Code of Federal Regulations sets out the following topics:[2]

  • Donor Screening and Testing: the determination of donor suitability for human tissue intended for transplantation.
  • Procedures and Records: the written procedures and records that must be kept
  • Inspection of Tissue Establishments: the importation of tissues from abroad and the retention, recall, and destruction of human tissue.

Notable regulation cases

  • Biomedical Tissue Services, Inc. is at the heart of an investigation by the Food and Drug Administration. [2]

External links

Footnotes

  1. Human Tissue Authority. "Remit".
  2. Food and Drug Administration (2003). "Part 1270: 'Human Tissue Intended for Transplantation'". Title 21--Food and Drugs. Code of Federal Regulations.

Template:Organ transplantation Template:SIB

Template:WH Template:WS